Number of the records: 1
Significance of plasma fibrinogen and malondialdehyde in the post-inflammatory period in patients with cystic fibrosis
SYS 0179764 LBL 00000naa--2200000-a-4500 005 20250607174459.5 008 220316s2022----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng $b eng 044 $a xo $c SK 245 10
$a Significance of plasma fibrinogen and malondialdehyde in the post-inflammatory period in patients with cystic fibrosis / $c Hloch Ondrej ... [et al.] 300 $b ilustr., obr., tab. 504 $a Bibliogr. odkazy 504 $a Res. angl. 650 12
$7 sllk_us_auth*d003550 $a fibróza cystická $2 mesh 650 22
$7 sllk_us_auth*d007249 $a zápal $2 mesh 650 22
$7 sllk_us_auth*d015415 $a biomarkery $2 mesh 650 12
$7 sllk_us_auth*d005340 $a fibrinogén $2 mesh 650 22
$7 sllk_us_auth*d008315 $a malóndialdehyd $2 mesh 650 22
$7 sllk_us_auth*d011379 $a prognóza $2 mesh 653 2-
$a markery zápalové 653 2-
$a kapacita pľúcna za prvú sekundu (FEV1) 653 2-
$a vyhodnotenie súboru pacientov 700 1-
$7 sllk_us_auth*0044441 $a Hloch, Ondřej $u Interní klinika, 2. LF UK a FN v Motole, Praha $4 aut 773 0-
$7 nnas $w sllk_us_cat*0179401 $t Bratislavské lekárske listy $x 0006-9248 $d Bratislava : AEPress, 2022 $g Vol. 123, no. 3 (2022), s. 149-152
Number of the records: 1